Aug 11, 2026 7:00 am EDT IDEXX Expands Catalyst Platform into Cardiac Disease with First and Only Dual-Species Point-of-Care NT-proBNP Test
Jul 28, 2026 7:00 am EDT IDEXX Releases 2025 Corporate Responsibility Report, Highlighting Progress Against Its Goals
May 26, 2026 7:00 am EDT IDEXX Expands Fecal Dx Antigen Testing Platform with Taeniid Tapeworm Detection
May 14, 2026 4:34 pm EDT IDEXX Laboratories to Present at Stifel Conference and Announces 2026 Investor Day